youtube_live
Q3 2026 earnings • in 4 days
See detailschevron_right
EDIT:NASDAQ
Editas Medicine Inc
၂.၅၇ US$
arrow_upward
+၀.၇၈%(+၀.၀၂၀) 1D
၂.၅၇ US$
၀.၀၀% (၀.၀၀)
bedtimeAfter hours
Closed: နို ၆, GMT-၅ ၁၆:၀၀:၀၁ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
၂.၅၅ US$
High
၂.၆၃ US$
Low
၂.၄၈ US$
Mkt. cap
၃၉.၄၇ ကုဋေ
Avg. vol.
၂.၃၃ သန်း
Volume
၁.၇၂ သန်း
52-wk high
၃.၉၄ US$
52-wk low
၁.၆၆ US$
EPS
-၀.၇၄ US$
Beta
၂.၀၉
Shares outstanding
၁၅.၃၆ ကုဋေ
No. of employees
၈၇
Open
၂.၅၅ US$
High
၂.၆၃ US$
Low
၂.၄၈ US$
Mkt. cap
၃၉.၄၇ ကုဋေ
Avg. vol.
၂.၃၃ သန်း
Volume
၁.၇၂ သန်း
52-wk high
၃.၉၄ US$
52-wk low
၁.၆၆ US$
EPS
-၀.၇၄ US$
Beta
၂.၀၉
Shares outstanding
၁၅.၃၆ ကုဋေ
No. of employees
၈၇
News stories
From web sources and news partners
Zacks
·
ပြီးခဲ့သည့် ၁ ရက်
Intellia Therapeutics, Inc. (NTLA) Reports Q3 Loss, Lags Revenue Estimates
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc